Table 1 General characteristics of patients
From: Periorbital changes associated with prostaglandin analogs in Korean patients
Numbers of patients (eyes) | 58 |
|---|---|
Age (years) | 61.05 ± 15.81 |
Gender (male: female) | 39: 19 |
Duration of treatment (months) | 26.76 ± 31.25 |
Pre-treatment IOP (mmHg) | 19.17 ± 6.70 |
IOP lowering effect (%) | 25.03 ± 18.47 |
Visual field index | 81.22 ± 22.91 |
History of cataract surgery (%) | 17 (29.31) |
Type of glaucoma (%) | |
NTG: POAG: Others | 38(65.51): 9(15.52): 11(18.97) |
Type of Prostaglandin analogs | |
Latanoprost: Bimatoprost: Travoprost | 50(86.21): 4(6.90): 4(6.90) |
Combination of other eyedrops (%) | 23 (39.66) |